{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T23:03:35Z","timestamp":1776467015560,"version":"3.51.2"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,5,11]],"date-time":"2012-05-11T00:00:00Z","timestamp":1336694400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2012,5,11]],"date-time":"2012-05-11T00:00:00Z","timestamp":1336694400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>The purpose of this study was to evaluate and compare the serum levels and local expression of resistin in patients with idiopathic inflammatory myopathies to controls, and to determine the relationship between resistin levels, inflammation and disease activity.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>Serum resistin levels were determined in 42 patients with inflammatory myopathies and 27 healthy controls. The association among resistin levels, inflammation, global disease activity and muscle strength was examined. The expression of resistin in muscle tissues from patients with inflammatory myopathies and healthy controls was evaluated. Gene expression and protein release from resistin-stimulated muscle and mononuclear cells were assessed.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>In patients with inflammatory myopathies, the serum levels of resistin were significantly higher than those observed in controls (8.53 \u00b1 6.84 vs. 4.54 \u00b1 1.08 ng\/ml, <jats:italic>P<\/jats:italic> &lt; 0.0001) and correlated with C-reactive protein (CRP) levels (r = 0.328, <jats:italic>P<\/jats:italic> = 0.044) and myositis disease activity assessment visual analogue scales (MYOACT) (r = 0.382, <jats:italic>P<\/jats:italic> = 0.026). Stronger association was observed between the levels of serum resistin and CRP levels (r = 0.717, <jats:italic>P<\/jats:italic> = 0.037) as well as MYOACT (r = 0.798, <jats:italic>P<\/jats:italic> = 0.007), and there was a trend towards correlation between serum resistin and myoglobin levels (r = 0.650, <jats:italic>P<\/jats:italic> = 0.067) in anti-Jo-1 positive patients. Furthermore, in patients with dermatomyositis, serum resistin levels significantly correlated with MYOACT (r = 0.667, <jats:italic>P<\/jats:italic> = 0.001), creatine kinase (r = 0.739, <jats:italic>P<\/jats:italic> = 0.001) and myoglobin levels (r = 0.791, <jats:italic>P<\/jats:italic> = 0.0003) and showed a trend towards correlation with CRP levels (r = 0.447, <jats:italic>P<\/jats:italic> = 0.067). Resistin expression in muscle tissue was significantly higher in patients with inflammatory myopathies compared to controls, and resistin induced the expression of interleukins (IL)-1\u03b2 and IL-6 and monocyte chemoattractant protein (MCP)-1 in mononuclear cells but not in myocytes.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>The results of this study indicate that higher levels of serum resistin are associated with inflammation, higher global disease activity index and muscle injury in patients with myositis-specific anti-Jo-1 antibody and patients with dermatomyositis. Furthermore, up-regulation of resistin in muscle tissue and resistin-induced synthesis of pro-inflammatory cytokines in mononuclear cells suggest a potential role for resistin in the pathogenesis of inflammatory myopathies.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/ar3836","type":"journal-article","created":{"date-parts":[[2012,5,11]],"date-time":"2012-05-11T12:14:58Z","timestamp":1336738498000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Resistin in idiopathic inflammatory myopathies"],"prefix":"10.1186","volume":"14","author":[{"given":"M\u00e1ria","family":"Filkov\u00e1","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hana","family":"Hulejov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kl\u00e1ra","family":"Kuncov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lenka","family":"Ple\u0161tilov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucie Andr\u00e9s","family":"Cerezo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He\u0159man","family":"Mann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josef","family":"Z\u00e1me\u010dn\u00edk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steffen","family":"Gay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji\u0159\u00ed","family":"Vencovsk\u00fd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ladislav","family":"\u0160enolt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,5,11]]},"reference":[{"key":"3613_CR1","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","volume":"362","author":"MC Dalakas","year":"2003","unstructured":"Dalakas MC, Hohlfeld R: Polymyositis and dermatomyositis. Lancet. 2003, 362: 971-982. 10.1016\/S0140-6736(03)14368-1.","journal-title":"Lancet"},{"key":"3613_CR2","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1097\/BOR.0b013e3283317b31","volume":"21","author":"B De Paepe","year":"2009","unstructured":"De Paepe B, Creus KK, De Bleecker JL: Role of cytokines and chemokines in idiopathic inflammatory myopathies. Curr Opin Rheumatol. 2009, 21: 610-616. 10.1097\/BOR.0b013e3283317b31.","journal-title":"Curr Opin Rheumatol"},{"key":"3613_CR3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.clim.2009.07.013","volume":"133","author":"M Filkov\u00e1","year":"2009","unstructured":"Filkov\u00e1 M, Haluz\u00edk M, Gay S, Senolt L: The role of resistin as a regulator of inflammation: Implications for various human pathologies. Clin Immunol. 2009, 133: 157-170. 10.1016\/j.clim.2009.07.013.","journal-title":"Clin Immunol"},{"key":"3613_CR4","doi-asserted-by":"publisher","first-page":"5789","DOI":"10.4049\/jimmunol.174.9.5789","volume":"174","author":"M Bokarewa","year":"2005","unstructured":"Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A: Resistin, an adipokine with potent proinflammatory properties. J Immunol. 2005, 174: 5789-5795.","journal-title":"J Immunol"},{"key":"3613_CR5","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1210\/jc.2006-2545","volume":"92","author":"PD Anderson","year":"2007","unstructured":"Anderson PD, Mehta NN, Wolfe ML, Hinkle CC, Pruscino L, Comiskey LL, Tabita-Martinez J, Sellers KF, Rickels MR, Ahima RS, Reilly MP: Innate immunity modulates adipokines in humans. J Clin Endocrinol Metab. 2007, 92: 2272-2279. 10.1210\/jc.2006-2545.","journal-title":"J Clin Endocrinol Metab"},{"key":"3613_CR6","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1371\/journal.pmed.0010045","volume":"1","author":"M Lehrke","year":"2004","unstructured":"Lehrke M, Reilly MP, Millington SC, Iqbal N, Rader DJ, Lazar MA: An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med. 2004, 1: e45-10.1371\/journal.pmed.0010045.","journal-title":"PLoS Med"},{"key":"3613_CR7","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.bbrc.2003.07.003","volume":"309","author":"S Kaser","year":"2003","unstructured":"Kaser S, Kaser A, Sandhofer A, Ebenbichler CF, Tilg H, Patsch JR: Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem Biophys Res Commun. 2003, 309: 286-290. 10.1016\/j.bbrc.2003.07.003.","journal-title":"Biochem Biophys Res Commun"},{"key":"3613_CR8","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1371\/journal.pone.0000031","volume":"1","author":"I Nagaev","year":"2006","unstructured":"Nagaev I, Bokarewa M, Tarkowski A, Smith U: Human resistin is a systemic immune-derived proinflammatory cytokine targeting both leukocytes and adipocytes. PLoS ONE. 2006, 1: e31-10.1371\/journal.pone.0000031.","journal-title":"PLoS ONE"},{"key":"3613_CR9","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.cardiores.2006.01.015","volume":"70","author":"H Mu","year":"2006","unstructured":"Mu H, Ohashi R, Yan S, Chai H, Yang H, Lin P, Yao Q, Chen C: Adipokine resistin promotes in vitro angiogenesis of human endothelial cells. Cardiovasc Res. 2006, 70: 146-157. 10.1016\/j.cardiores.2006.01.015.","journal-title":"Cardiovasc Res"},{"key":"3613_CR10","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1161\/01.CIR.0000084503.91330.49","volume":"108","author":"S Verma","year":"2003","unstructured":"Verma S, Li SH, Wang CH, Fedak PW, Li RK, Weisel RD, Mickle DA: Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation. 2003, 108: 736-740. 10.1161\/01.CIR.0000084503.91330.49.","journal-title":"Circulation"},{"key":"3613_CR11","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.bbrc.2003.12.104","volume":"314","author":"D Kawanami","year":"2004","unstructured":"Kawanami D, Maemura K, Takeda N, Harada T, Nojiri T, Imai Y, Manabe I, Utsunomiya K, Nagai R: Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions. Biochem Biophys Res Commun. 2004, 314: 415-419. 10.1016\/j.bbrc.2003.12.104.","journal-title":"Biochem Biophys Res Commun"},{"key":"3613_CR12","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1093\/rheumatology\/kem088","volume":"46","author":"J Tomasov\u00e1 Studynkov\u00e1","year":"2007","unstructured":"Tomasov\u00e1 Studynkov\u00e1 J, Charv\u00e1t F, Jarosov\u00e1 K, Vencovsky J: The role of MRI in the assessment of polymyositis and dermatomyositis. Rheumatology (Oxford). 2007, 46: 1174-1179. 10.1093\/rheumatology\/kem088.","journal-title":"Rheumatology (Oxford)"},{"key":"3613_CR13","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1056\/NEJM199111213252107","volume":"325","author":"MC Dalakas","year":"1991","unstructured":"Dalakas MC: Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med. 1991, 325: 1487-1498.","journal-title":"N Engl J Med"},{"key":"3613_CR14","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1212\/WNL.61.3.288","volume":"61","author":"AA Amato","year":"2003","unstructured":"Amato AA, Griggs RC: Unicorns, dragons, polymyositis, and other mythological beasts. Neurology. 2003, 61: 288-289. 10.1212\/WNL.61.3.288.","journal-title":"Neurology"},{"key":"3613_CR15","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/01.md.0000173991.74008.b0","volume":"84","author":"Y Troyanov","year":"2005","unstructured":"Troyanov Y, Targoff IN, Tremblay JL, Goulet JR, Raymond Y, Sen\u00e9cal JL: Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients. Medicine (Baltimore). 2005, 84: 231-249. 10.1097\/01.md.0000173991.74008.b0.","journal-title":"Medicine (Baltimore)"},{"key":"3613_CR16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/rheumatology\/keg427","volume":"43","author":"DA Isenberg","year":"2004","unstructured":"Isenberg DA, Allen E, Farewell V, Ehrenstein MR, Hanna MG, Lundberg IE, Oddis C, Pilkington C, Plotz P, Scott D, Vencovsky J, Cooper R, Rider L, Miller F, International Myositis and Clinical Studies Group (IMACS): International Myositis and Clinical Studies Group (IMACS). International consensus outcome measures for patients with idiopathic infl ammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. Rheumatology(Oxford). 2004, 43: 49-54. 10.1093\/rheumatology\/keg427.","journal-title":"Rheumatology(Oxford)"},{"key":"3613_CR17","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/acr.20035","volume":"62","author":"LG Rider","year":"2010","unstructured":"Rider LG, Koziol D, Giannini EH, Jain MS, Smith MR, Whitney-Mahoney K, Feldman BM, Wright SJ, Lindsley CB, Pachman LM, Villalba ML, Lovell DJ, Bowyer SL, Plotz PH, Miller FW, Hicks JE: Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies. Arthritis Care Res (Hoboken). 2010, 62: 465-472. 10.1002\/acr.20035.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"3613_CR18","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1001\/jama.290.13.1709-c","volume":"290","author":"A Sch\u00e4ffler","year":"2003","unstructured":"Sch\u00e4ffler A, Ehling A, Neumann E, Herfarth H, Tarner I, Sch\u00f6lmerich J, M\u00fcller-Ladner U, Gay S: Adipocytokines in synovial fluid. JAMA. 2003, 290: 1709-1710. 10.1001\/jama.290.13.1709-c.","journal-title":"JAMA"},{"key":"3613_CR19","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1136\/ard.2006.054734","volume":"66","author":"L Senolt","year":"2007","unstructured":"Senolt L, Housa D, Vernerov\u00e1 Z, Jir\u00e1sek T, Svobodov\u00e1 R, Veigl D, Anderlov\u00e1 K, M\u00fcller-Ladner U, Pavelka K, Haluz\u00edk M: Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum. Ann Rheum Dis. 2007, 66: 458-463.","journal-title":"Ann Rheum Dis"},{"key":"3613_CR20","first-page":"698","volume":"24","author":"K Migita","year":"2006","unstructured":"Migita K, Maeda Y, Miyashita T, Kimura H, Nakamura M, Ishibashi H, Eguchi K: The serum evels of resistin in rheumatoid arthritis patients. Clin Exp Rheumatol. 2006, 24: 698-701.","journal-title":"Clin Exp Rheumatol"},{"key":"3613_CR21","doi-asserted-by":"publisher","first-page":"R15","DOI":"10.1186\/ar2366","volume":"10","author":"K Almehed","year":"2008","unstructured":"Almehed K, d'Elia HF, Bokarewa M, Carlsten H: Role of resistin as a marker of inflammation in systemic lupus erythematosus. Arthritis Res Ther. 2008, 10: R15-10.1186\/ar2366.","journal-title":"Arthritis Res Ther"},{"key":"3613_CR22","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.3899\/jrheum.110237","volume":"38","author":"JF Baker","year":"2011","unstructured":"Baker JF, Morales M, Qatanani M, Cucchiara A, Nackos E, Lazar MA, Teff K, Von Feldt JM: Resistin levels in lupus and associations with disease-specific measures, insulin resistance, and coronary calcification. J Rheumatol. 2011, 38: 2369-2375. 10.3899\/jrheum.110237.","journal-title":"J Rheumatol"},{"key":"3613_CR23","first-page":"779","volume":"23","author":"M Karalaki","year":"2009","unstructured":"Karalaki M, Fili S, Philippou A, Koutsilieris M: Muscle regeneration: cellular and molecular events. In Vivo. 2009, 23: 779-796.","journal-title":"In Vivo"},{"key":"3613_CR24","doi-asserted-by":"publisher","first-page":"R1173","DOI":"10.1152\/ajpregu.00735.2009","volume":"298","author":"JG Tidball","year":"2010","unstructured":"Tidball JG, Villalta SA: Regulatory interactions between muscle and the immune system during muscle regeneration. Am J Physiol Regul Integr Comp Physiol. 2010, 298: R1173-1187. 10.1152\/ajpregu.00735.2009.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"3613_CR25","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/j.1365-2796.2010.02334.x","volume":"269","author":"I Loell","year":"2011","unstructured":"Loell I, Lundberg IE: Can muscle regeneration fail in chronic inflammation: a weakness in inflammatory myopathies?. J Intern Med. 2011, 269: 243-257. 10.1111\/j.1365-2796.2010.02334.x.","journal-title":"J Intern Med"},{"key":"3613_CR26","doi-asserted-by":"publisher","first-page":"5789","DOI":"10.4049\/jimmunol.174.9.5789","volume":"174","author":"M Bokarewa","year":"2005","unstructured":"Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A: Resistin, an adipokine with potent proinflammatory properties. J Immunol. 2005, 174: 5789-5795.","journal-title":"J Immunol"},{"key":"3613_CR27","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1007\/s004010051041","volume":"97","author":"A Liprandi","year":"1999","unstructured":"Liprandi A, Bartoli C, Figarella-Branger D, Pellissier JF, Lepidi H: Local expression of monocyte chemoattractant protein-1 (MCP-1) in idiopathic inflammatory myopathies. Acta Neuropathol. 1999, 97: 642-648. 10.1007\/s004010051041.","journal-title":"Acta Neuropathol"},{"key":"3613_CR28","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/1529-0131(200002)43:2<336::AID-ANR13>3.0.CO;2-V","volume":"43","author":"I Lundberg","year":"2000","unstructured":"Lundberg I, Kratz AK, Alexanderson H, Patarroyo M: Decreased expression of interleukin-1alpha, interleukin-1beta, and cell adhesion molecules in muscle tissue following corticoid treatment in patients with polymyositis and dermatomyositis. Arthritis Rheum. 2000, 43: 336-348. 10.1002\/1529-0131(200002)43:2<336::AID-ANR13>3.0.CO;2-V.","journal-title":"Arthritis Rheum"},{"key":"3613_CR29","doi-asserted-by":"publisher","first-page":"3436","DOI":"10.1002\/art.24936","volume":"60","author":"H Bilgic","year":"2009","unstructured":"Bilgic H, Ytterberg SR, Amin S, McNallan KT, Wilson JC, Koeuth T, Ellingson S, Newman B, Bauer JW, Peterson EJ, Baechler EC, Reed AM: Interleukin-6 and type I interferon-regulated genes and chemokines mark disease activity in dermatomyositis. Arthritis Rheum. 2009, 60: 3436-3446. 10.1002\/art.24936.","journal-title":"Arthritis Rheum"},{"key":"3613_CR30","first-page":"41","volume":"21","author":"Z Mackiewicz","year":"2003","unstructured":"Mackiewicz Z, Hukkanen M, Povilenaite D, Sukura A, Fonseca JE, Virtanen I, Konttinen YT: Dual effects of caspase-1, interleukin-1 beta, tumour necrosis factor-alpha and nerve growth factor receptor in inflammatory myopathies. Clin Exp Rheumatol. 2003, 21: 41-48.","journal-title":"Clin Exp Rheumatol"},{"key":"3613_CR31","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s10067-009-1316-7","volume":"29","author":"GT Kim","year":"2010","unstructured":"Kim GT, Cho ML, Park YE, Yoo WH, Kim JH, Oh HJ, Kim DS, Baek SH, Lee SH, Lee JH, Kim HY, Kim SI: Expression of TLR2, TLR4, and TLR9 in dermatomyositis and polymyositis. Clin Rheumatol. 2010, 29: 273-279. 10.1007\/s10067-009-1316-7.","journal-title":"Clin Rheumatol"},{"key":"3613_CR32","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1111\/j.1582-4934.2009.00899.x","volume":"14","author":"A Tarkowski","year":"2010","unstructured":"Tarkowski A, Bjersing J, Shestakov A, Bokarewa MI: Resistin competes with lipopolysaccharide for binding to toll-like receptor 4. J Cell Mol Med. 2010, 14: 1419-1431.","journal-title":"J Cell Mol Med"},{"key":"3613_CR33","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s11926-010-0101-6","volume":"12","author":"SA Greenberg","year":"2010","unstructured":"Greenberg SA: Dermatomyositis and type 1 interferons. Curr Rheumatol Rep. 2010, 12: 198-203. 10.1007\/s11926-010-0101-6.","journal-title":"Curr Rheumatol Rep"},{"key":"3613_CR34","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1002\/art.33350","volume":"64","author":"A Tournadre","year":"2012","unstructured":"Tournadre A, Lenief V, Eljaafari A, Miossec P: Immature muscle precursors are a source of interferon-\u03b2 in myositis: role of Toll-like receptor 3 activation and contribution to HLA class I up-regulation. Arthritis Rheum. 2012, 64: 533-541.","journal-title":"Arthritis Rheum"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar3836.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/ar3836\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar3836.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T10:33:16Z","timestamp":1728383596000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/ar3836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,11]]},"references-count":34,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2012,6]]}},"alternative-id":["3613"],"URL":"https:\/\/doi.org\/10.1186\/ar3836","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,11]]},"assertion":[{"value":"10 January 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R111"}}